All In Biotech

Drug Trial Radar · NCT03833700

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

An Open-label Phase 1 Study of E7386 in Subjects With Advanced Solid Tumor Including Colorectal Cancer

Last checked: Nov 19, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Mar 5, 2019

Primary completion

Mar 31, 2027

Study completion Mar 31, 2027

Sponsor

Lead sponsor
Eisai Co., Ltd.Eisai
Sponsor type
Industry
First posted
Feb 7, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will be conducted to assess the safety and tolerability of E7386 in participants with solid tumor including CRC.

Conditions

  • Solid Neoplasms
  • Colorectal Neoplasms
  • Gastrointestinal Tumors

Interventions

  • E7386Drug

    E7386 doses.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Dose-limiting Toxicities (DLTs)Time frame: Baseline up to Cycle 1 (Cycle length is equal to [=] 28 days)
  2. Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: Up to 30 days after the last dose of study drug or before initiating post anti-cancer treatment (approximately 6 years)

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Eisai Trial Site #4

    Fukuoka, Japan

  • Eisai Trial Site#6

    Osaka, Japan

  • Eisai Trial Site#7

    Nagoya, Aichi-ken, Japan

  • Eisai Trial Site #2

    Kashiwa, Chiba, Japan

  • Eisai Trial Site #5

    Sapporo, Hokkaido, Japan

  • Eisai Trial Site#8

    Sendai, Miyagi, Japan

  • Eisai Trial Site #3

    Nagaizumi-cho, Shizuoka, Japan

  • Eisai Trial Site #1

    Chuo Ku, Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.